Therapie der chronisch rezidivierenden idiopathischen Pyodermie des Hundes mit Staphylokokken-Vakzinen

Zusammenfassung

Staphylokokken-Vakzinen sind eine sinnvolle therapeutische Alternative zur herkömmlichen antibakteriellen Therapie bei der chronisch rezidivierenden Pyodermie des Hundes ohne feststellbare zugrundeliegende Erkrankung. Zu Beginn der Therapie sollte die Vakzine für mehrere Wochen mit anderen antimikrobiellen Behandlungen kombiniert werden. Der Therapieerfolg einer solchen Vakzine sollte erst nach 10, besser 18 Wochen beurteilt werden. Die Herstellung der Vakzine hat maßgeblichen Einfluss auf die Nebenwirkungen und die Wirksamkeit.

Summary

Staphylococcal vaccines are a good therapeutic alternative to the classic antibacterial treatments in dogs with chronic recurrent pyoderma without detectable underlying diseases. At the beginning of this therapy, the vaccine should be combined with other antimicrobial treatments for several weeks. Treatment success should be judged after 10, or better, 18 weeks. Differences in the production processes of the vaccine will influence the adverse effects and the success rate.

Schlüsselwörter

Bakterielle Vakzine - chronisch wiederkehrende idiopathische Pyodermie - bakterielle Dermatitis - immunmodulierende Therapie

Key words

Bacterial vaccines - chronic recurrent idiopathic pyoderma - bacterial dermatitis - immunomodulatory therapy

• Literatur

• 1 Bannoehr J, Ben Zakour NL, Waller AS, Guardabassi L, Thoday KL, van den Broek AH. et al. Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains. J Bacteriol 2007; 189 (23) 8685-8692.
• 2 Becker AM, Janik TA, Smith EK, Sousa CA, Peters BA. Propionibacterium acnes immunotherapy in chronic recurrent canine pyoderma. An adjunct to antibiotic therapy. J Vet Int Med 1989; 03 (01) 26-30.
• 3 Bell A. Prophylaxis of German Shepherd Recurrent Furunculosis (German Shepherd Dog Pyoderma) Using Cephalexin Pulse Therapy. Aust Vet Pract 1995; 25 (01) 30-36.
• 4 Curtis C. Canine idiopathic recurrent superficial pyoderma. Vet Rec 1998; 143 (12) 344.
• 5 Curtis CF, Lamport AI, Lloyd DH. Masked, controlled study to investigate the efficacy of a Staphylococcus intermedius autogenous bacterin for the control of canine idiopathic recurrent superficial pyoderma. Vet Dermatol 2006; 17 (03) 163-168.
• 6 Day MJ. Possible immunodeficiency in related rottweiler dogs. J Small Anim Pract 1999; 40 (12) 561-568.
• 7 DeBoer DJ, Moriello KA, Thomas CB, Schultz KT. Evaluation of a commercial staphylococcal bacterin for management of idiopathic recurrent superficial pyoderma in dogs. Am J Vet Res 1990; 51 (04) 636-639.
• 8 Foster AP. Immunomodulation and immunodeficiency. Vet Dermatol 2004; 15 (02) 115-126.
• 9 Helton-Rhodes K. Feline immunomodulators. In: Current Veterinary Therapy XII. Bonagura JD. ed. Philadelphia: Saunders; 1995: 581-584.
• 10 Hill PB, Lo A, Eden CA, Huntley S, Morey V, Ramsey S. et al. Survey of the prevalence, diagnosis and treatment of dermatological conditions in small animals in general practice. Vet Rec 2006; 158 (16) 533-539.
• 11 Kwochka KW. Recurrent pyoderma. In: Current Veterinary Dermatology. Griffin CE. ed. Philadelphia: Mosby; 1993: 3.
• 12 Löwenstein C. Pyodermie beim Hund. Tierärztl Prax 2011; 39 (K): 405-417.
• 13 Mayr A, Selmair J, Schels H. Erfahrungen mit Autovakzine-Therapie bei der Staphylokokken-Pyodermie des Hundes. Tierärztl Umsch 1987; 42: 112-118.
• 14 Rosser EJ. German Shepherd Dog pyoderma. Vet Clin North Am Small Anim Pract 2006; 36 (01) 203-211.
• 15 Schwarz S, Noble WC. Aspects of bacterial resistance to antimicrobials used in veterinary dermatological practice. Vet Dermatol 1999; 10 (03) 163-176.
• 16 Schwassman M. Uses of interferon. AAVD Newsletter. 1999: 9.
• 17 Scott DW, Miller WH, Griffin CE. Muller and Kirk’s Small Animal Dermatology. 6th edn.. Philadelphia: Saunders; 2001
• 18 Scott DW, Paradis M. A survey of canine and feline skin disorders seen in a university practice: Small Animal Clinic, University of Montréal, Saint-Hyacinthe, Québec (1987–1988). Can Vet J 1990; 31 (12) 830-835.
• 19 Trepanier LA. Delayed hypersensitivity reactions to sulphonamides: syndromes, pathogenesis and management. Vet Dermatol 1999; 10 (03) 241-248.
• 20 Whitbread TJ, Batt RM, Garthwaite G. Relative deficiency of serum IgA in the german shepherd dog: a breed abnormality. Res Vet Sci 1984; 37 (03) 350-352.
• 21 White SD, Carlotti DN, Pin D, Bonenberger T, Ihrke PJ, Monet E. et al. Putative drug-related pemphigus foliaceus in four dogs. Vet Dermatol 2002; 13 (04) 195-202.
• 22 White SD. Systemic treatment of bacterial skin infections of dogs and cats. Vet Dermatol 1996; 07 (03) 133-143.